Francis Medical launches commercial Vanquish procedures for prostate tissue ablation. Explore what this means for minimally invasive prostate cancer treatment.
Nuventus launches NV.C Implant System in the United States, highlighting preservation-focused implant design. Discover what this means for clinicians and the market.
FDA clears expanded capabilities for Bayer MRXperion MRI injector supporting scanners up to 7T. Discover what this means for imaging workflows and radiology systems.
Pete Pharma and Atrium24 partner to expand pharmaceutical 3D printing in independent pharmacies. Explore what this shift means for drug manufacturing.
CereVasc’s eShunt system shows three-year outcomes in idiopathic intracranial hypertension. Discover what this means for future brain pressure treatments.
Airiver Medical wins FDA Breakthrough Device status for its pulmonary drug coated balloon. Discover what this means for airway stenosis treatment and clinical trials.
Intrinsic Therapeutics launches the Barricaid Narrow Anchor for lumbar discectomy patients. Explore what the smaller implant could change in spine surgery.
Insight Molecular Diagnostics advances GraftAssureDx toward FDA submission. Discover what this means for transplant rejection testing and dd-cfDNA diagnostics.
Median Technologies advances eyonis LCS after FDA clearance. Discover what this means for AI lung cancer screening and European expansion.
Lucent Diagnostics partners with Life Line Screening to expand Alzheimer’s blood testing nationwide. Discover what this means for early detection.